DOJ Clarifies Position on Fraud-on-the-FDA Theory of False Claims Act Liability - Lexology
On June 3, 2022, the Washington, D.C., office of the Civil Division of the Department of Justice (DOJ) filed a statement of interest in a relator’s action in the Southern District of Florida, cap...
Read more